Potential applications and performance of machine learning techniques and algorithms in clinical practice: A systematic review
Potential applications and performance of machine learning techniques and algorithms in clinical practice: A systematic review
PURPOSE: The advent of clinically adapted machine learning algorithms can solve numerous problems ranging from disease diagnosis and prognosis to therapy recommendations. This systematic review examines the performance of machine learning (ML) algorithms and evaluates the progress made to date towards their implementation in clinical practice.
METHODS: Systematic searching of databases (PubMed, MEDLINE, Scopus, Google Scholar, Cochrane Library and WHO Covid-19 database) to identify original articles published between January 2011 and October 2021. Studies reporting ML techniques in clinical practice involving humans and ML algorithms with a performance metric were considered.
RESULTS: Of 873 unique articles identified, 36 studies were eligible for inclusion. The XGBoost (extreme gradient boosting) algorithm showed the highest potential for clinical applications (n = 7 studies); this was followed jointly by random forest algorithm, logistic regression, and the support vector machine, respectively (n = 5 studies). Prediction of outcomes (n = 33), in particular Inflammatory diseases (n = 7) received the most attention followed by cancer and neuropsychiatric disorders (n = 5 for each) and Covid-19 (n = 4). Thirty-three out of the thirty-six included studies passed more than 50% of the selected quality assessment criteria in the TRIPOD checklist. In contrast, none of the studies could achieve an ideal overall bias rating of 'low' based on the PROBAST checklist. In contrast, only three studies showed evidence of the deployment of ML algorithm(s) in clinical practice.
CONCLUSIONS: ML is potentially a reliable tool for clinical decision support. Although advocated widely in clinical practice, work is still in progress to validate clinically adapted ML algorithms. Improving quality standards, transparency, and interpretability of ML models will further lower the barriers to acceptability.
Algorithms, COVID-19, Humans, Logistic Models, Machine Learning, SARS-CoV-2
104679
Nwanosike, Ezekwesiri Michael
cfa7e99a-976a-43c3-8c46-00669d8e5da4
Conway, Barbara R
2c87aa00-8c01-480c-befb-6092900011c9
Merchant, Hamid A
16e7d300-a50c-480f-99f5-86e30e9274ec
Hasan, Syed Shahzad
e402cff7-ef4d-431e-8b82-905d3c8cfb89
1 March 2022
Nwanosike, Ezekwesiri Michael
cfa7e99a-976a-43c3-8c46-00669d8e5da4
Conway, Barbara R
2c87aa00-8c01-480c-befb-6092900011c9
Merchant, Hamid A
16e7d300-a50c-480f-99f5-86e30e9274ec
Hasan, Syed Shahzad
e402cff7-ef4d-431e-8b82-905d3c8cfb89
Nwanosike, Ezekwesiri Michael, Conway, Barbara R, Merchant, Hamid A and Hasan, Syed Shahzad
(2022)
Potential applications and performance of machine learning techniques and algorithms in clinical practice: A systematic review.
International Journal of Medical Informatics, 159, .
(doi:10.1016/j.ijmedinf.2021.104679).
Abstract
PURPOSE: The advent of clinically adapted machine learning algorithms can solve numerous problems ranging from disease diagnosis and prognosis to therapy recommendations. This systematic review examines the performance of machine learning (ML) algorithms and evaluates the progress made to date towards their implementation in clinical practice.
METHODS: Systematic searching of databases (PubMed, MEDLINE, Scopus, Google Scholar, Cochrane Library and WHO Covid-19 database) to identify original articles published between January 2011 and October 2021. Studies reporting ML techniques in clinical practice involving humans and ML algorithms with a performance metric were considered.
RESULTS: Of 873 unique articles identified, 36 studies were eligible for inclusion. The XGBoost (extreme gradient boosting) algorithm showed the highest potential for clinical applications (n = 7 studies); this was followed jointly by random forest algorithm, logistic regression, and the support vector machine, respectively (n = 5 studies). Prediction of outcomes (n = 33), in particular Inflammatory diseases (n = 7) received the most attention followed by cancer and neuropsychiatric disorders (n = 5 for each) and Covid-19 (n = 4). Thirty-three out of the thirty-six included studies passed more than 50% of the selected quality assessment criteria in the TRIPOD checklist. In contrast, none of the studies could achieve an ideal overall bias rating of 'low' based on the PROBAST checklist. In contrast, only three studies showed evidence of the deployment of ML algorithm(s) in clinical practice.
CONCLUSIONS: ML is potentially a reliable tool for clinical decision support. Although advocated widely in clinical practice, work is still in progress to validate clinically adapted ML algorithms. Improving quality standards, transparency, and interpretability of ML models will further lower the barriers to acceptability.
This record has no associated files available for download.
More information
Accepted/In Press date: 27 December 2021
e-pub ahead of print date: 31 December 2021
Published date: 1 March 2022
Additional Information:
Copyright © 2021 Elsevier B.V. All rights reserved.
Keywords:
Algorithms, COVID-19, Humans, Logistic Models, Machine Learning, SARS-CoV-2
Identifiers
Local EPrints ID: 485160
URI: http://eprints.soton.ac.uk/id/eprint/485160
ISSN: 1386-5056
PURE UUID: 430e31ad-139a-4aa1-8398-9bb47d59558f
Catalogue record
Date deposited: 30 Nov 2023 17:41
Last modified: 18 Mar 2024 04:17
Export record
Altmetrics
Contributors
Author:
Ezekwesiri Michael Nwanosike
Author:
Barbara R Conway
Author:
Hamid A Merchant
Author:
Syed Shahzad Hasan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics